Quality Assessment of Serially Ultradiluted and Agitated Drug Digitalis purpurea by Emission Spectroscopy and Clinical Analysis of Its Effect on the Heart Rate of Indian Bufo melanostictus

Table 4

Linear regression analysis. The medicines used were analyzed groupwise as given before. Total no. of obs. = 7382; df = model: 8, Residual: 7373, Prob. > 𝐹=0.0000; R-squared = 0.1613; Adj. R-squared = 0.1604; Root MSE = 148.47.

RR interval	Coef.	Std. Err.	𝑡	𝑃>|𝑡|	(95% conf. interval)
					Lower limit	Upper limit
Rectified spirit (medicine_1)	56.12259	6.464837	8.68	0.000	43.44966	68.79551
Ether (medicine_2)	138.1445	11.78828	11.72	0.000	115.0361	161.2529
Digitalis purpurea θ (medicine_3)	36.68673	7.024809	5.22	0.000	22.91609	50.45736
Digitalis purpurea 6 (medicine_4)	64.35277	8.299983	7.75	0.000	48.08243	80.62311
Digitalis purpurea 30 (medicine_5)	70.56156	5.815624	12.13	0.000	59.16127	81.96184
Digitalis purpurea 200 (medicine_6)	47.93883	9.036935	5.30	0.000	30.22386	65.65381
Digoxin (medicine_7)	8.956708	10.4319	0.86	0.391	−11.4928	29.40622
Bufo no.	−1.359518	0.0621821	−21.86	0.000	−1.481413	−1.237623
cons	731.6598	5.034684	145.32	0.000	721.7904	741.5292